Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer

Bibliographic Details
Main Authors:	Athanassios Argiris, Lisa Licitra
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Series:	Frontiers in Oncology
Subjects:	systemic therapy chemotherapy cetuximab head and neck cancer squamous cell carcinoma of the head and neck human papillomavirus
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.01190/full

Similar Items

Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy
by: Sandro V. Porceddu, et al.
Published: (2020-01-01)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
by: Miren Taberna, et al.
Published: (2019-05-01)

Incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with cetuximab
by: Tomohiro Enokida, et al.
Published: (2016-09-01)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
by: Athanassios Argiris, et al.
Published: (2017-05-01)

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers
by: Sandra Ortiz-Cuaran, et al.
Published: (2021-02-01)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
by: Kunal eSaigal, et al.
Published: (2014-06-01)

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
by: Greg Knutzen, et al.
Published: (2015-11-01)

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
by: Thomas Chevalier, et al.
Published: (2021-06-01)

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
by: Kedar Kirtane, et al.
Published: (2018-12-01)

Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer
by: Muge Akmansu, et al.
Published: (2010-12-01)

Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neck
by: Jacques Bernier
Published: (2011-12-01)

Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
by: Akash Mathur, et al.
Published: (2018-01-01)

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
by: Emmanuel Seront, et al.
Published: (2019-03-01)

Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
by: Erik Haehl, et al.
Published: (2020-02-01)

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
by: Ines De Pauw, et al.
Published: (2018-06-01)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
by: Tomohiro Enokida, et al.
Published: (2020-03-01)

Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas
by: Yuil Kim, et al.
Published: (2020-09-01)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
by: Olivia Leblanc, et al.
Published: (2020-02-01)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Ross Zeitlin, et al.
Published: (2015-04-01)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
by: Tomohiro Enokida, et al.
Published: (2018-08-01)

Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma
by: Jameel Muzaffar, et al.
Published: (2021-01-01)

Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
by: Loris De Cecco, et al.
Published: (2017-01-01)

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
by: Il Seok Daniel Jeong, et al.
Published: (2020-08-01)

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
by: Alexander Rühle, et al.
Published: (2020-04-01)

Targeting interleukin-6 trans-signaling in head and neck squamous cell carcinoma
by: Dahl, Rachel A.
Published: (2018)

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
by: Himani Aggarwal, et al.
Published: (2020-06-01)

Segmented and total direct cost-of-care for advanced squamous cell carcinoma of the head and neck in a privately insured population
by: Reveles, Ivan Alexander
Published: (2013)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

A pilot study to profile salivary angiogenic factors to detect head and neck cancers
by: L. van der Merwe, et al.
Published: (2018-07-01)

Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence
by: Rony Benson, et al.
Published: (2016-09-01)

RADIOCHEMOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMA – LJUBLJANA EXPERIENCE
by: Lojze Šmid, et al.
Published: (2002-12-01)

Head and neck cancers: Regional trends in Kashmir
by: Shahid Rasool, et al.
Published: (2017-01-01)

Prevalence of Head and Neck Cancer in Gilan Province, Iran: A 10-Year Study
by: F Shahsavari, et al.
Published: (2017-07-01)

The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
by: Alexander Rühle, et al.
Published: (2020-06-01)

DNA Methylation and HPV-Associated Head and Neck Cancer
by: Takuya Nakagawa, et al.
Published: (2021-04-01)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
by: Shinya Uozumi, et al.
Published: (2018-12-01)

Detection of High Risk Human Papillomavirus DNA Sequences in Head and Neck Squamous Cell Carcinoma in Iranian Fanconi Anemia Patients
by: Anahita Mohseni Meybodi, et al.
Published: (2010-01-01)

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)
by: Sadamoto Zenda, et al.
Published: (2019-01-01)

Basaloid squamous cell carcinoma of the head and neck: Our experience
by: Jaimanti Bakshi, et al.
Published: (2020-01-01)